| Economic burden of seasonal influenza in the United States |
45 |
| Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017 |
42 |
| How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015 |
41 |
| Polarization of the vaccination debate on Facebook |
41 |
| mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials |
35 |
| Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity |
33 |
| Parental vaccine hesitancy in Italy - Results from a national survey |
30 |
| Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake |
28 |
| Typhoid vaccines: WHO position paper, March 2018-Recommendations |
28 |
| It's not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook |
27 |
| Polysaccharides as vaccine adjuvants |
26 |
| Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study |
24 |
| Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide |
23 |
| Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity |
23 |
| Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg- using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults |
23 |
| African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses |
23 |
| Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates |
22 |
| Bacillus Calmette-Guerin (BCG) vaccine: A global assessment of demand and supply balance |
22 |
| Explanations for the high potency of HPV prophylactic vaccines |
22 |
| Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus |
22 |
| A report on the status of vaccination in Europe |
22 |
| The influence of the intestinal microbiome on vaccine responses |
21 |
| Hepatitis B vaccines: WHO position paper, July 2017-Recommendations |
21 |
| Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies |
21 |
| Status of HPV vaccine introduction and barriers to country uptake |
21 |
| Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen |
20 |
| Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015 |
20 |
| Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis |
20 |
| Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology |
19 |
| Rabies vaccines: WHO position paper, April 2018-Recommendations |
19 |
| Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India |
18 |
| Attitudes, believes, determinants and organisational barriers behind the low seasonal influenza vaccination uptake in healthcare workers - A cross-sectional survey |
17 |
| Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis |
17 |
| National survey of pharmacy-based immunization services |
16 |
| The rotavirus vaccine development pipeline |
16 |
| Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs |
16 |
| Vaccination against the human cytomegalovirus |
16 |
| Understanding barriers and predictors of maternal immunization: Identifying gaps through an exploratory literature review |
16 |
| BCG vaccine: WHO position paper, February 2018-Recommendations World Health Organization |
16 |
| Recent vaccine mandates in the United States, Europe and Australia: A comparative study |
15 |
| Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development |
15 |
| Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis |
15 |
| Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network) |
15 |
| Why France is making eight new vaccines mandatory |
15 |
| Vaccination of healthcare personnel in Europe: Update to current policies |
15 |
| Sharing knowledge about immunisation (SKAI): An exploration of parents' communication needs to inform development of a clinical communication support intervention |
15 |
| Trust collapse caused by the Changsheng vaccine crisis in China |
14 |
| Cost-effectiveness of dengue vaccination in ten endemic countries |
14 |
| Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine |
14 |
| Personalized vaccinology: A review |
14 |
